Bacterial Pathogens Activate a Common Inflammatory Pathway through IFNλ Regulation of PDCD4

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Cohen, Taylor S ^a   Prince, Alice S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; LYMPHOCYTE ANTIGEN; MICRORNA; MICRORNA 21; PROGRAMMED CELL DEATH PROTEIN 4; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CYTOKINES; EPITHELIAL CELLS; HUMANS; LUNG; MICE; MICE, KNOCKOUT; MICRORNAS; PNEUMONIA, STAPHYLOCOCCAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; RNA-BINDING PROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 84887310638     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003682     Document Type: Article

References (60)

1. Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, et al. (2012) Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 46: 6-13 doi:10.1165/rcmb.2011-0080OC.
2. Parker D, Prince A, (2012) Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol 189: 4040-4046 doi:10.4049/jimmunol.1201055.
3. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, et al. (2011) Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2: e00016-11 doi:10.1128/mBio.00016-11.
4. David M, (2010) Interferons and microRNAs. Journal of Interferon & Cytokine Research 30: 825-828 doi:10.1089/jir.2010.0080.
5. Trinchieri G, (2010) Type I interferon: friend or foe? Journal of Experimental Medicine 207: 2053-2063 doi:10.1084/jem.20101664.
6. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531 doi:10.1038/nrg1379.
7. Ma X, Becker Buscaglia LE, Barker JR, Li Y, (2011) MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 3: 159-166 doi:10.1093/jmcb/mjr007.
8. O'Neill LA, Sheedy FJ, McCoy CE, (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11: 163-175 doi:10.1038/nri2957.
9. Quinn SR, O'Neill LA, (2011) A trio of microRNAs that control Toll-like receptor signalling. International Immunology 23: 421-425 doi:10.1093/intimm/dxr034.
10. Yasuda M, Schmid T, Rübsamen D, Colburn NH, Irie K, et al. (2010) Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment. Mol Carcinog 49: 837-848 doi:10.1002/mc.20660.
11. Cohen TS, Prince AS, (2013) Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. J Clin Invest 123: 1630-1637 doi:10.1172/JCI66142DS1.
12. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033 doi:10.1074/jbc.M707224200.
13. Martin FJ, Gómez MI, Wetzel DM, Memmi G, O'Seaghdha M, et al. (2009) Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest. 119: 1931-1939.
14. Martin FJ, Parker D, Harfenist BS, Soong G, Prince A, (2011) Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun 79: 1898-1904 doi:10.1128/IAI.01299-10.
15. Carrigan SO, Junkins R, Yang YJ, Macneil A, Richardson C, et al. (2010) IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J Immunol 185: 3602-3609 doi:10.4049/jimmunol.0903429.
16. Power MR, Li B, Yamamoto M, Akira S, Lin T-J, (2007) A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice. J Immunol 178: 3170-3176.
17. Dennis MD, Jefferson LS, Kimball SR, (2012) Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis. Journal of Biological Chemistry 287: 42890-42899 doi:10.1074/jbc.M112.404822.
18. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77 doi:10.1038/ni875.
19. Liwak U, Thakor N, Jordan LE, Roy R, Lewis SM, et al. (2012) Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2. Mol Cell Biol 32: 1818-1829 doi:10.1128/MCB.06317-11.
20. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68 doi:10.1038/ni873.
21. de Weerd NA, Nguyen T, (2012) The interferons and their receptors--distribution and regulation. Immunology and Cell Biology 90: 483-491 doi:10.1038/icb.2012.9.
22. Kroczynska B, Sharma B, Eklund EA, Fish EN, Platanias LC, (2012) Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses. Mol Cell Biol 32: 2809-2822 doi:10.1128/MCB.00310-12.
23. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M, (2005) Biological activity of interleukins-28 and-29: comparison with type I interferons. Cytokine 31: 109-118 doi:10.1016/j.cyto.2005.04.003.
24. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, et al. (2008) IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 7: 1109-1115.
25. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, et al. (2008) An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 180: 2474-2485.
26. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, et al. (2007) Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81: 7749-7758 doi:10.1128/JVI.02438-06.
27. Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, et al. (2010) Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 84: 8626-8638 doi:10.1128/JVI.00303-10.
28. Sommereyns C, Paul S, Staeheli P, Michiels T, (2008) IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017 doi:10.1371/journal.ppat.1000017.
29. Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, et al. (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21. Science Signaling 4: ra75-ra75 Available: http://stke.sciencemag.org/cgi/content/abstract/sigtrans4/199/ra75.
30. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, et al. (2009) Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 182: 1296-1304.
31. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. (2009) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141-147 doi:10.1038/ni.1828.
32. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84: 11515-11522 doi:10.1128/JVI.01703-09.
33. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, et al. (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20: 669-676 doi:10.1038/sj.onc.1204137.
34. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, et al. (2011) IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 3: 348-361 doi:10.1002/emmm.201100142.
35. Gallagher G, Megjugorac NJ, Yu RY, Eskdale J, Gallagher GE, et al. (2010) The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response. Journal of Interferon & Cytokine Research 30: 603-615 doi:10.1089/jir.2010.0081.
36. Pekarek V, Srinivas S, Eskdale J, Gallagher G, (2007) Interferon lambda-1 (IFN-λ1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 8: 177-180 doi:10.1038/sj.gene.6364372.
37. Chastre J, Fagon J-Y, (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165: 867-903.
38. Centers for Disease Control and Prevention (CDC) (2003) Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 52: 992-996.
39. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, et al. (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131: 1887-1898 doi:10.1053/j.gastro.2006.09.052.
40. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, et al. (2006) Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44: 896-906 doi:10.1002/hep.21312.
41. Gómez MI, Seaghdha MO, Prince AS, (2007) Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J 26: 701-709 doi:10.1038/sj.emboj.7601554.
42. Gómez MI, Lee A, Reddy B, Muir A, Soong G, et al. (2004) Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 10: 842-848 doi:10.1038/nm1079.
43. Gómez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS, (2006) Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 281: 20190-20196.
44. Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, et al. (2005) Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65: 11282-11286 doi:10.1158/0008-5472.CAN-05-3469.
45. Wedeken L, Singh P, Klempnauer K-H, (2011) Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. Journal of Biological Chemistry 286: 42855-42862 doi:10.1074/jbc.M111.269456.
46. Wedeken L, Ohnheiser J, Hirschi B, Wethkamp N, Klempnauer K-H, (2010) Association of tumor suppressor protein Pdcd4 with ribosomes is mediated by protein-protein and protein-RNA interactions. Genes & Cancer 1: 293-301 doi:10.1177/1947601910364227.
47. Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T, (2006) Antitumor activity of IFN-lambda in murine tumor models. J Immunol 176: 7686-7694.
48. Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, et al. (2006) Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res 66: 4468-4477 doi:10.1158/0008-5472.CAN-05-3653.
49. Dickensheets H, Sheikh F, Park O, Gao B, Donnelly RP, (2013) Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes. J Leukoc Biol 93: 377-385 doi:10.1189/jlb.0812395.
50. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401 doi:10.1038/nature08309.
51. Lebreton A, Lakisic G, Job V, Fritsch L, Tham TN, et al. (2011) A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 331: 1319-1321 doi:10.1126/science.1200120.
52. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, et al. (2008) PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. PNAS 105: 3274-3279 doi:10.1073/pnas.0712235105.
53. Liu X, Zhan Z, Xu L, Ma F, Li D, et al. (2010) MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. J Immunol 185: 7244-7251 doi:10.4049/jimmunol.1001573.
54. Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, et al. (2012) MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 18: 267-273 doi:10.1038/nm.2584.
55. Case SR, Martin RJ, Jiang D, Minor MN, Chu HW, (2011) MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp Lung Res 37: 500-508 doi:10.3109/01902148.2011.596895.
56. Lu TX, Hartner J, Lim E-J, Fabry V, Mingler MK, et al. (2011) MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 187: 3362-3373 doi:10.4049/jimmunol.1101235.
57. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, et al. (2011) The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic {beta} cell death. PNAS 108: 12030-12035 doi:10.1073/pnas.1101450108/-/DCSupplemental/pnas.201101450SI.pdf.
58. Parker D, Prince A, (2013) Epithelial uptake of flagella initiates proinflammatory signaling. PLoS ONE 8: e59932 doi:10.1371/journal.pone.0059932.g005.
59. Mijares LA, Wangdi T, Sokol C, Homer R, Medzhitov R, et al. (2011) Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J Immunol 186: 7080-7088 doi:10.4049/jimmunol.1003687.
60. Chun J, Prince A, (2009) TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 5: 47-58 doi:10.1016/j.chom.2008.11.009.